Stanford Health Care-Sponsored Stanford University Neuromuscular Medicine (Neurology)

Topics

• Muscle Physiology and Disorders 106
• Genetic Neurodegenerative Diseases 92
• Neurogenetic and Muscular Disorders Research 85
• Myasthenia Gravis and Thymoma 65
• Hereditary Neurological Disorders 48
• Amyotrophic Lateral Sclerosis Research 44
• Peripheral Neuropathies and Disorders 39
• Glioma Diagnosis and Treatment 30
• Peripheral Nerve Disorders 26
• Parkinson's Disease Mechanisms and Treatments 25
• Neurological disorders and treatments 20
• Cardiovascular Syncope and Autonomic Disorders 19

Most cited

1. GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas.

   Nature · 2022 · 697 citations · Hannes Vogel

2. AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial.

   Nature medicine · 2025 · 143 citations · Crystal Proud

3. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation.

   Cell · 2022 · 426 citations · Hannes Vogel

4. GABAergic neuron-to-glioma synapses in diffuse midline gliomas.

   Nature · 2025 · 103 citations · Hannes Vogel

5. Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial.

   The Lancet. Neurology · 2021 · 399 citations · John Day

6. Risdiplam in Type 1 Spinal Muscular Atrophy.

   The New England journal of medicine · 2021 · 347 citations · John Day

7. Long-term wireless streaming of neural recordings for circuit discovery and adaptive stimulation in individuals with Parkinson's disease.